Zellen fahren gerne Fahrrad

2599–2608.
Fung TT, Rexrode KM, Mantzoros CS, Manson JE, Willett WC, Hu FB: Mediterranean diet and incidence of and mortality from coronary heart disease and stroke in women, Circulation 2009, 119(8): 1093–1100.
Giugliano D, Ceriello A, Esposito K: The effects of diet on inflammation: emphasis on the metabolic syndrome, J Am Coll Cardiol 2006; 48(4): 677–685.
Ferrieres J: The French paradox: lessons for other countries, Heart 2004; 90(1): 107–111.
Harris WS, Sands SA, Windsor SL et al.: Omega-3 fatty acids in cardiac biopsies from heart transplantation patients: correlation with erythrocytes and response to supplementation, Circulation 2004, 110(12): 1645–1649.
Harris WS, von SC: The Omega-3 Index: a new risk factor for death from coronary heart disease?, Prev Med 2004, 39(1): 212–220.
Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto miocardico: Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial, Lancet 1999, 354(9177): 447–455.
Marchioli R, Barzi F, Bomba E et al.: Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico (GISSI)-Prevenzione, Circulation 2002, 105(16): 1897–1903.
Mozaffarian D, Katan MB, Ascherio A, Stampfer MJ, Willett WC: Trans fatty acids and cardiovascular disease, N Engl J Med 2006, 354(15): 1601–1613.
Angell SY, Silver LD, Goldstein GP et al.: Cholesterol control beyond the clinic: New York City’s trans fat restriction, Ann Intern Med 2009, 151(2): 129–134.
Yusuf S, Hawken S, Ounpuu S et al.: Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study, Lancet 2004, 364(9438): 937–952.
Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C: Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis, JAMA 2007, 297(8): 842–857.
Luppi P, Cifarelli V, Tse H, Piganelli J, Trucco M: Human C-peptide antagonises high glucose-induced endothelial dysfunction through the nuclear factorkappaB pathway, Diabetologia 2008, 51(8): 1534–1543.
Cifarelli V, Geng X, Styche A, Lakomy R, Trucco M, Luppi P: C-peptide reduces
high-glucose-induced apoptosis of endothelial cells and decreases NAD(P)H-oxidase reactive oxygen species generation in human aortic endothelial cells, Diabetologia 2011, 54(10): 2702–2712.
Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M: Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction, N Engl J Med 1998, 339(4): 229–234.
Assmann G, Cullen P, Schulte H: Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Munster (PROCAM) study. Circulation 2002; 105(3): 310–315.
Yusuf S, Hawken S, Ounpuu S et al.: Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004; 364(9438): 937–952.
Sui X, LaMonte MJ, Laditka JN et al.: Cardiorespiratory fitness and adiposity as mortality predictors in older adults. JAMA 2007; 298(21): 2507–2516.
D’Agostino RB, Sr., Vasan RS, Pencina MJ et al.: General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 2008; 117(6): 743–753.
Lee DC, Sui X, Church TS, Lavie CJ, Jackson AS, Blair SN: Changes in fitness and fatness on the development of cardiovascular disease risk factors hypertension, metabolic syndrome, and hypercholesterolemia. J Am Coll Cardiol 2012; 59(7): 665–672.

Dank
    Herzlichen Dank
    • allen meinen Mitarbeitern des Zentrums für Prävention und Sportmedizin an der Technischen Universität in München, die mir ständig Anregungen geben, mich fordern und unterstützen,
    • den Verantwortlichen an der Technischen Universität und am Klinikum rechts der Isar, die meine Arbeit am Lehrstuhl und meine Initiative zur Etablierung von Prävention und Sporttherapie an einer Universität und Universitätsklinik unterstützen,
    • den Verantwortlichen des Bereichs »Gesundheitsmanagement« der BMW group, Herrn Dr. Bischof, Frau Dr. Richter, Herrn Dr. Ring, Herrn Westermaier, mit denen